Sandoz Group AG

Swiss Stock Exchange SDZ.SW

Sandoz Group AG Total Non-Current Liabilities for the year ending December 31, 2023: USD 5.08 B

Sandoz Group AG Total Non-Current Liabilities is USD 5.08 B for the year ending December 31, 2023, a 521.58% change year over year. Total non-current liabilities are the sum of long-term debt and other non-current liabilities.
  • Sandoz Group AG Total Non-Current Liabilities for the year ending December 31, 2022 was USD 816.95 M, a -11.58% change year over year.
  • Sandoz Group AG Total Non-Current Liabilities for the year ending December 31, 2021 was USD 923.91 M, a -2.41% change year over year.
  • Sandoz Group AG Total Non-Current Liabilities for the year ending December 31, 2020 was USD 946.71 M.
Key data
Date Total Non-Current Liabilities Shareholders' Equity Other Liabilities Total Liabilities
Market news
SV Wall Street
Swiss Stock Exchange: SDZ.SW

Sandoz Group AG

CEO Mr. Richard Saynor
IPO Date Oct. 3, 2023
Location Switzerland
Headquarters Suurstoffi 14
Employees 22,633
Sector Healthcare
Industries
Pharmaceuticals Biotechnology Cosmetics Plastics Vaccines
Description

Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. It develops, manufactures, and markets finished dosage forms of small molecule pharmaceuticals to third parties. It also provides protein- or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services; and anti-infectives, such as active pharmaceutical ingredients and intermediates primarily antibiotics. The company was founded in 1886 and is headquartered in Rotkreuz, Switzerland.

StockViz Staff

February 7, 2025

Any question? Send us an email